Time filter

Source Type

Liaocheng, China

Liu W.-K.,Xian University of Science and Technology | Jiang X.-Y.,Renmin Hospital | Zhang Z.-X.,Xian University of Science and Technology
Onkologie | Year: 2010

Background: Endometrial cancer is the 4th most common gynecological cancer. The expression of prostate stem cell antigen (PSCA), piwi-like 1 (PIWIL1), and T-box 2 (TBX2) in endometrial cancer remains to be elucidated. Material and Methods: The expression of PSCA, PIWIL1, and TBX2 was examined using the streptavidin-peroxidase method in 64 endometrial endometrioid adenocarcinoma (EAC) and paired normal endometrium (NE) samples from the Shaanxi Province in Ch na. Results: Positive expression rates of PSCA, PIWIL1, and TBX2 were 75% (48/64), 25% (16/64), and 56% (36/64), respectively in EACs, but 5% (3/64), 6% (4/64), and 2% (1/64), respectively in NEs. The difference was statistically significant (p < 0.05). PSCA was positively correlated with TBX2 (p = 0.003) but not PIWIL1 (p = 0.188). PIWIL1 was positively correlated with TBX2 (p = 0.003). PSCA was positively correlated with age, tumor grade, and lymph node metastasis (p < 0.05). TBX2 had an association with lymph node metastasis (p = 0.014). PIWIL1 was not associated with clinicopathological features (p > 0.05). Conclusions: We report the first analysis of PSCA, PIWIL1, and TBX2 expression in EAC. Our findings suggest that PSCA and TBX2 might be candidate targets for cancer therapy, and have helped us further understand the carcinogenesis of endometrial cancer. Copyright © 2010 S. Karger AG, Basel. Source

Yan X.-L.,Tianjin Huanhu Hospital | Shi S.-L.,Renmin Hospital | Zhang X.-B.,Tianjin Huanhu Hospital | Tang F.,Tianjin Huanhu Hospital | Jin S.-M.,Tianjin Huanhu Hospital
Chinese Journal of Contemporary Neurology and Neurosurgery | Year: 2015

Objective: To study clinicopathological features, diagnosis, differential diagnosis and prognosis of mixed adenoneuroendocrine carcinoma (MANEC). Methods: One case of MANEC with brain metastasis was reported focusing on the following aspects: clinical manifestations, histopathological features and immunophenotypes, and the relevant literatures were reviewed. Results: A 35-year-old male presented headache and vomiting, and his head CT scan showed a lesion located in the right temporal lobe. The tumor was detected after separating the cerebral cortex during the surgery. The tumor diameter was 3 cm. The tumor was soft and rubbery with ill-defined margins, and rich in blood supply. Under optical microscopy, the tumor was consisted of small round cells of the same size, with focal tumor cells arranged around blood vessels in a pseudorosette manner or papillary manner with brisk mitotic activity. The boundary between tumor and brain tissue was ill-defined. By using immunohistochemical staining, the tumor cells were diffusely positive for synaptophysin (Syn) and CD56, and negative for glial fibrillary acidic protein (GFAP), pan cytokeratin (PCK), CD3, CD20, vimentin (Vim), leukocyte common antigen (LCA), thyroid transcription factor-1 (TTF-1), S-100 protein (S-100), neurofilament (NF), nestin (Nes), CK5/6, CK8/ 18 and CD99. Ki-67 labeling index was about 62%. Sigmoidoscopy was performed later in another hospital and showed a mass in the patient's colon. The colon tumor was biphasic in appearance, and was consisted of two distinct components: isomorphic small round cells and low-middle differentiated adenocarcinoma cells. The small round tumor cells were diffusely positive for Syn and CD56, and negative for PCK. The adenocarcinoma cells showed opposite results. Conclusions: MANEC is a rare tumor, which is defined in 2010 by WHO Classification of Digestive, and to the best of our knowledge, MANEC of the colon with brain metastasis has never been described. Therefore, this paper reports the first case of MANEC of the colon with brain metastasis. Definite diagnosis could be made by medical history, typical histopathological characteristics and immunohistochemical expressions. ©, 2015, Tianjin Huanhu Hospital. All right reserved. Source

Li W.C.,Wuhan University | Zhang H.M.,Hubei University of Medicine | Li J.,Hubei University of Medicine | Dong R.K.,Renmin Hospital | And 4 more authors.
Transplantation Proceedings | Year: 2013

Background: Pigs have been regarded as the preferred source of organs for human xenotransplantation. The aim of the present study was to explore the biomechanical properties of the bile duct in pigs and humans to provide evidence for liver xenotransplantation. Materials and methods: Fresh bile duct specimens obtained from 50 pigs aged 3 to 12 months and five deceased human donors. The diameters and wall thickness of the bile duct were measured using a computer imaging analysis system. The pressure-diameter of bile ducts was tested with biomechanical equipment. The corresponding parameters were calculated: incremental elastic moduli (Einc), pressure-strain elastic modulus (Ep), volume elastic modulus (Ev), and compliance. Results: The Einc, Ep, and Ev of porcine bile duct gradually decreases with age. However, the Einc, Ep, and Ev gradually increased after pigs aged 10 months. The E inc, Ep, and Ev of pig bile ducts aged 3 to 6, and 11 to 12 months were higher than that of humans aged 20 to 40 years (P <.01). The changes in compliance of the porcine bile duct with age oppose those in elastic modulus. There were no significant differences in the elastic modulus and compliance of the bile duct between pigs aged 7 to 10 months and adult humans (P >.05). Conclusions: The biomechanical properties of the bile duct of pigs aged 7 to 10 months match that of adult humans. The correlation between age and biomechanical properties of bile ducts in pigs implied that a pig aged 7 to 10 months should be chosen for pig-to-human liver xenotransplantation. © 2013 Elsevier Inc. Source

Xue R.,Renmin University of China | Lei S.,Renmin University of China | Lei S.,Wenzhou University | Xia Z.-Y.,Renmin University of China | And 10 more authors.
Clinical Science | Year: 2016

Patients with diabetes are vulnerable to MI/R (myocardial ischaemia/reperfusion) injury, but are not responsive to IPostC (ischaemic post-conditioning) which activates PI3K (phosphoinositide 3-kinase)/Akt (also known as PKB or protein kinase B) and JAK2 (Janus kinase 2)/STAT3 (signal transducer and activator of transcription 3) pathways to confer cardioprotection. We hypothesized that increased cardiac PTEN (phosphatase and tensin homologue deleted on chromosome 10), a major negative regulator of PI3K/Akt, is responsible for the loss of diabetic heart sensitivity to IPostC cardioprotecton. In STZ (streptozotocin)-induced Type 1 diabetic rats subjected to MI/R (30 min coronary occlusion and 120 min reperfusion), the post-ischaemic myocardial infarct size, CK-MB (creatine kinase-MB) and 15-F2t-isoprostane release, as well as cardiac PTEN expression were significantly higher than those in non-diabetic controls, concomitant with more severe cardiac dysfunction and lower cardiac Akt, STAT3 and GSK-3β (glycogen synthase kinase 3β) phosphorylation. IPostC significantly attenuated post-ischaemic infarct size, decreased PTEN expression and further increased Akt, STAT3 and GSK-3β phosphorylation in non-diabetic, but not in diabetic rats. Application of the PTEN inhibitor BpV (bisperoxovanadium) (1.0 mg/kg) restored IPostC cardioprotection in diabetic rats. HPostC (hypoxic post-conditioning) in combination with PTEN gene knockdown, but not HPostC alone, significantly reduced H/R (hypoxia/reoxygenation) injury in cardiac H9c2 cells exposed to high glucose as was evident from reduced apoptotic cell death and JC-1 monomer in cells, accompanied by increased phosphorylation of Akt, STAT3 and GSK-3β. PTEN inhibition/gene knockdown mediated restoration of IPostC/HPostC cardioprotection was completely reversed by the PI3K inhibitor wortmannin, and partially reversed by the JAK2 inhibitor AG490. Increased cardiac PTEN, by impairing PI3K/Akt and JAK2/STAT3 pathways, is a major mechanism that rendered diabetic hearts not responsive to post-conditioning cardioprotection. © 2016 Authors. Source

Chen F.-C.,Hubei University of Medicine | Shi X.-Y.,Hubei University of Medicine | Li P.,Hubei University of Medicine | Yang J.-G.,Hubei University of Medicine | And 2 more authors.
Medicine (United States) | Year: 2015

Tropisetron is an adjuvant for butorphanol used in intravenous patientcontrolled analgesia (PCA) and has been reported to provide superior pain control. It is efficacious in reducing the incidence of postoperative nausea and vomiting. However, this admixture is not available commercially and stability data applicable to hospital practice are limited. This study aimed to describe the drug compounding and evaluates the long-term (up to 14 days) stability of butorphanol and tropisetron in 0.9% sodium chloride injection for PCA use. In this study, commercial solutions of butorphanol tartrate and tropisetron hydrochloride were combined and further diluted with 0.9% sodium chloride injection to final concentrations of butorphanol tartrate 0.08 mg/mL and tropisetron hydrochloride 0.05 mg/mL. The polyolefin bags and glass bottles were stored at 4°C and 25°C for up to 14 days. The drug stabilities were determined by visual inspection, pH measurement, and high-pressure liquid chromatography assay of drug concentrations. The data obtained for admixtures prepared and stored at temperatures of 25°C and 4°C show the drugs have maintained at least 98% of the initial concentration. All solutions remained clear and colorless over the 14-day period, and the pH value did not change significantly. The results indicate that admixtures of butorphanol tartrate 0.08 mg/mL and tropisetron hydrochloride 0.05 mg/mL in 0.9% sodium chloride injection solution were stable for 14 days when stored in polyolefin bags or glass bottles at 4°C and 25°C and protected from light. The infusion is feasible for manufacturing in pharmacy aseptic units and can be stored for up to 14 days for routine use in PCA infusions. Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. Source

Discover hidden collaborations